Partial response of metastatic hepatocellular carcinoma after treatment with thymostimulin.
We describe a case of partial regression of metastatic hepatocellular carcinoma after treatment with thymostimulin. The patient, a 58-year-old man, received no specific therapy for his tumor, but only a thymus extract ("thymostimulin"). At follow-up 6 months later the patient showed clinical improvement, reduction of alpha-fetoprotein level an liver lesions, and a complete regression of lung metastases. The patient died of progression of the disease with 2-year overall survival.
Palmieri
G
G
Istituto di Oncologia, II Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli, Italy.
Gridelli
C
C
Pepe
R
R
Airoma
G
G
Iaffaioli
R V
RV
Frasci
G
G
Caponigro
F
F
Bianco
A R
AR
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D013949:Thymus Extracts; C031407:thymostimulin